Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes.
Little is known about the assembly of the 28-nm nucleocapsid or core particle of hepatitis B virus. Here we show that this assembly process can be reconstituted in Xenopus oocytes injected with a synthetic mRNA encoding the hepatitis B virus capsid protein (p21.5). Injected oocytes produce both a nonparticulate p21.5 species (free p21.5) and capsid particles. We describe rapid and simple methods for fractionating these species on a small scale either with step gradients of 10 to 60% (wt/vol) sucrose or by centrifugation to pellet the particles, and we characterize the oocyte core particles. Free p21.5 exhibits chemical and physical properties distinctly different from those of particles. Free p21.5 is partially cleaved by proteinase K, whereas core particles are almost completely resistant to cleavage. This suggests that the carboxyl-terminal protamine region, the main target for proteases within p21.5, is exposed in free p21.5 but faces the interior of the p21.5 core particle. Finally, pulse-chase experiments demonstrated that free p21.5 can be chased almost quantitatively into core particles, establishing that free p21.5 is fully competent to form particles and represents an assembly intermediate on the pathway for core particle formation. However, core particle assembly appears very dependent on p21.5 concentration and is rapidly compromised if the p21.5 concentration is lowered. The advantages of oocytes for studying assembly are discussed.
Zhou
S
S
Hormone Research Institute, University of California, San Francisco 94143-0534.
Yang
S Q
SQ
Standring
D N
DN
D000818:Animals; D002213:Capsid / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D004279:DNA, Viral / Q000378:metabolism*; D019286:Endopeptidase K; D006515:Hepatitis B virus / Q000187:drug effects / Q000254:growth & development*; D009865:Oocytes; D011487:Protein Conformation; D012697:Serine Endopeptidases / Q000494:pharmacology; D014162:Transfection; D014758:Viral Core Proteins / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D014771:Virion / Q000187:drug effects / Q000254:growth & development*; D014779:Virus Replication; D014981:Xenopus
D004279:DNA, Viral; D014758:Viral Core Proteins; D012697:Serine Endopeptidases; D019286:Endopeptidase K